Pfizer R & D building at Wuhan, China
Pfizer leads the way for pharma companies at Biolake
By Wang Huazhong and Zhou Lihua | China Daily USA | Updated: 2016-06-29
In 2010 Pfizer was the first Fortune 500 company to settle in the newly established National Bio-industry Base in Wuhan, also known as Biolake.
Following in Pfizer's steps, eight of 13 pharmaceutical companies from the Fortune 500 list now have a presence at Biolake as the bio-industry base leads a State program to rely on innovation to upgrade the economic structure of Wuhan, which was once dominated by heavy industries and a renowned steel producer in central China.
“Every one of Pfizer's new drugs has indispensable contributions from the Wuhan team." According to Lan
"No other but our Wuhan teams manage the clinical trial registry information and clinical trial master files for all Pfizer's medicines. https://archive.md/puanr#selection-222.0-421.71
........................................................
By 2015 Pfizer was moving its “medicine safety business” from India to the Wuhan Biolake facility. https://archive.md/puanr
\
No comments:
Post a Comment